RIM
ALNY icon

Redpoint Investment Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Redpoint Investment Management’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$585K Buy
2,921
+431
+17% +$82.2K 0.09% 286
2022
Q2 		$363K Hold
2,490
– – 0.04% 455
2022
Q1 		$407K Hold
2,490
– – 0.04% 481
2021
Q4 		$422K Hold
2,490
– – 0.03% 492
2021
Q3 		$470K Hold
2,490
– – 0.04% 464
2021
Q2 		$422K Hold
2,490
– – 0.03% 504
2021
Q1 		$352K Hold
2,490
– – 0.03% 531
2020
Q4 		$324K Hold
2,490
– – 0.03% 464
2020
Q3 		$363K Buy
2,490
+789
+46% +$112K 0.04% 433
2020
Q2 		$252K Buy
+1,701
New +$229K 0.01% 522

Other funds holding ALNY

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Redpoint Investment Management's ALNY Position: Q3 2022 in Review

Redpoint Investment Management increased its Alnylam Pharmaceuticals (ALNY) stake by 17% in Q3 2022, buying an estimated $82.2K and bringing the position to 2,921 shares worth $585K. The position accounts for 0.09% of the portfolio, ranked #286.

Redpoint Investment Management first reported a position in ALNY in Q2 2020 and has held it in 10 quarters since. 496 funds tracked by Wall St. Rank hold ALNY as of Q3 2022.

  • Redpoint Investment Management held 2,921 shares of Alnylam Pharmaceuticals worth $585K as of Q3 2022.
  • Redpoint Investment Management bought 431 Alnylam Pharmaceuticals shares in Q3 2022, an estimated $82.2K.
  • Alnylam Pharmaceuticals made up 0.09% of Redpoint Investment Management's portfolio in Q3 2022, its #286 holding.
  • Redpoint Investment Management first reported a position in Alnylam Pharmaceuticals in Q2 2020 and has held it in 10 quarters since.
  • 496 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2022.

Based on Redpoint Investment Management's 13F filing for Q3 2022, filed 14 Oct 2022.